NCT06408142

Brief Summary

The goal of this study is to determine how many patients with HIV or at high risk of getting HIV attend the Emergency Department (ED) in South Africa (SA). The investigators will integrate HIV assessment in the ED and see how many people who would be a candidate for a drug that prevents HIV (PrEP). Universal test and connect (UTC) is a strategy that universally tests all patients and connects patients to long-term care, whether HIV positive or negative, including referrals for PrEP. The investigator's goal is to use UTC across two busy 24-hr EDs in Cape Town, SA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

May 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
1.7 years until next milestone

Study Start

First participant enrolled

January 19, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

May 6, 2024

Last Update Submit

January 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of potentially PrEP eligible patients in the ED

    Baseline survey, chart abstraction, and use of South Africa National Department of Health and Centers for Disease Control and Prevention (CDC) pre-exposure prophylaxis (PrEP) Eligibility Guidelines

    Baseline

Secondary Outcomes (4)

  • The number of potentially PrEP eligible patients with tuberculosis or acute HIV

    Baseline

  • The number of potentially PrEP eligible patients with renal dysfunction

    Baseline

  • The number of potentially PrEP eligible patients who report baseline difficulty to engage in follow up required to be on PrEP

    Baseline

  • Acceptability of ED PrEP to ED Providers

    after implementation of UTC

Study Arms (2)

Emergency Department Patients in South Africa

Universal Test and Connect: universal screening with HIV testing followed by demographic/clinical information to determine number of patients who would be eligible for HIV PrEP

Diagnostic Test: HIV testing

Emergency Department Providers

Nurses, physicians, or advanced practice providers who deliver care in the Emergency Department at one of the clinical sites

Other: In-depth interview

Interventions

HIV testingDIAGNOSTIC_TEST

Point of Care HIV testing universally regardless of risk factors

Emergency Department Patients in South Africa

In-depth interviews of providers using Normalization Process Theory semi-structured interview guide to assess provider perspectives of PrEP delivery in the ED

Emergency Department Providers

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cross-sectional population attending the Emergency Departments, which are both publicly available 24-hour Emergency Departments that serve the surrounding neighborhood/catchment area.

You may qualify if:

  • Patients attending the Emergency Department
  • Ages \> or = 12 years old in South Africa

You may not qualify if:

  • Patients unable to provide written informed consent - i.e., have a depressed level of consciousness (head trauma or concurrent alcohol/substance abuse), determined as critically ill (triage score of "emergent"), or
  • do not speak a language spoken by the study team (English, Afrikaans, and Xhosa).
  • In-depth interviews and surveys to providers:
  • Nurses, physicians, or advanced practice providers (APPs) who work regularly in the Emergency Department at one of the clinical sites.
  • Consent to a recorded in-depth interview and/or Normalizing Process Theory (NPT) survey
  • Providers who have already been interviewed (if working at both clinical sites)
  • Providers who do not consent to an interview or a survey.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gugulethu Community Health Centre

Cape Town, Western Cape, South Africa

RECRUITING

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeEmergencies

Interventions

HIV Testing

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Microbiological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Bhakti Hansoti, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Rudolph, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 9, 2024

Study Start

January 19, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

January 30, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Individual participant data will be available to other researchers that are explicitly on the IRB (Institutional Review Board) both at Johns Hopkins or on local IRBs at University of Cape Town and Stellenbosch University. All information will be de-identified while not on an encrypted password-protected database to ensure participant confidentiality

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Throughout duration of study period (anticipated 2027) and up to 5 years after.
Access Criteria
Researchers/analysts on the Institutional Review Board (IRB) submission at each of the IRB sites for this multi-center study

Locations